Clermont-Ferrand, France

Isabelle Batisson



Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2008-2014

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Isabelle Batisson

Introduction

Isabelle Batisson is a notable inventor based in Clermont-Ferrand, France. She has made significant contributions to the field of immunology, particularly in the development of antibodies that target virulence-associated proteins. With a total of 3 patents to her name, her work is paving the way for advancements in the prevention of infections in mammals.

Latest Patents

Isabelle's latest patents focus on antibodies that are immunologically specific for an attaching and effacing (AEEC) virulence-associated protein. These inventions include products, compositions, and methods aimed at preventing AEEC infections in mammals. The antibodies she has developed are capable of preventing in vivo AEEC intestinal infections when administered to mammals. Specifically, her work emphasizes the use of IgY antibodies that target various AEEC virulence-associated proteins, such as Eae, Tir, EspA, and Paa.

Career Highlights

Isabelle Batisson is associated with Valorisation-Recherche, Société En Commandite, where she continues to innovate and contribute to her field. Her research is crucial in understanding and combating AEEC infections, which can lead to serious intestinal lesions in mammals.

Collaborations

Isabelle has collaborated with notable colleagues, including John Morris Fairbrother and Josée Harel. These partnerships enhance her research and broaden the impact of her inventions.

Conclusion

Isabelle Batisson's work in developing specific antibodies for AEEC virulence-associated proteins represents a significant advancement in immunology. Her contributions are vital for the prevention of infections in mammals, showcasing her dedication to innovation in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…